BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1227 related articles for article (PubMed ID: 18052747)

  • 21. Effects of ticlopidine administered to healthy volunteers on platelet function in whole blood.
    Heptinstall S; May JA; Glenn JR; Sanderson HM; Dickinson JP; Wilcox RG
    Thromb Haemost; 1995 Nov; 74(5):1310-5. PubMed ID: 8607115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rat platelet aggregation by ATP. Aggregometrical and ultrastructural comparison with aggregations induced by ADP and collagen.
    Ts'ao C
    Am J Pathol; 1976 Dec; 85(3):581-94. PubMed ID: 998732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amifostine, a reactive oxigen species scavenger with radiation- and chemo-protective properties, inhibits in vitro platelet activation induced by ADP, collagen or PAF.
    Porta C; Maiolo A; Tua A; Grignani G
    Haematologica; 2000 Aug; 85(8):820-5. PubMed ID: 10942928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Augmentation of U46619 induced human platelet aggregation by aspirin.
    Kim JM; Koo YK; Jin J; Lee YY; Park S; Yun-Choi HS
    Platelets; 2009 Mar; 20(2):111-9. PubMed ID: 19235053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet aggregation, storage pool deficiency, and protein phosphorylation in mice with Chediak-Higashi syndrome.
    Pratt HL; Carroll RC; Jones JB; Lothrop CD
    Am J Vet Res; 1991 Jun; 52(6):945-50. PubMed ID: 1652907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Collagen-induced platelet aggregation: the role of adenine nucleotides and the release reaction.
    Kattlove H; Gomez MH
    Thromb Diath Haemorrh; 1975 Dec; 34(3):795-805. PubMed ID: 813326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Whole blood platelet aggregation in humans and animals: a comparative study.
    Soloviev MV; Okazaki Y; Harasaki H
    J Surg Res; 1999 Apr; 82(2):180-7. PubMed ID: 10090827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitory effect of hericenone B from Hericium erinaceus on collagen-induced platelet aggregation.
    Mori K; Kikuchi H; Obara Y; Iwashita M; Azumi Y; Kinugasa S; Inatomi S; Oshima Y; Nakahata N
    Phytomedicine; 2010 Dec; 17(14):1082-5. PubMed ID: 20637576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potentiation of thromboxane A2-induced platelet secretion by Gi signaling through the phosphoinositide-3 kinase pathway.
    Dangelmaier C; Jin J; Smith JB; Kunapuli SP
    Thromb Haemost; 2001 Feb; 85(2):341-8. PubMed ID: 11246558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deficiency of (33P)2MeS-ADP binding sites on platelets with secretion defect, normal granule stores and normal thromboxane A2 production. Evidence that ADP potentiates platelet secretion independently of the formation of large platelet aggregates and thromboxane A2 production.
    Cattaneo M; Lombardi R; Zighetti ML; Gachet C; Ohlmann P; Cazenave JP; Mannucci PM
    Thromb Haemost; 1997 May; 77(5):986-90. PubMed ID: 9184415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid stimulation of tyrosine phosphorylation signals downstream of G-protein-coupled receptors for thromboxane A2 in human platelets.
    Minuz P; Fumagalli L; Gaino S; Tommasoli RM; Degan M; Cavallini C; Lecchi A; Cattaneo M; Lechi Santonastaso C; Berton G
    Biochem J; 2006 Nov; 400(1):127-34. PubMed ID: 16859489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of MK-447 on platelet shape change, aggregation, and ATP release by collagen, ADP, and stable analogue of thromboxane A2 in rabbit platelets.
    Li BY; Zhou H; Qiao GF; Wang L; Li WH
    Zhongguo Yao Li Xue Bao; 1999 Jul; 20(7):627-30. PubMed ID: 10678127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostaglandin endoperoxides, thromboxane A2 and adenosine diphosphate in collagen-induced aggregation of rabbit platelets.
    Lewis GP; Watts IS
    Br J Pharmacol; 1982 Apr; 75(4):623-31. PubMed ID: 6802211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel thienylacylhydrazone derivatives inhibit platelet aggregation through cyclic nucleotides modulation and thromboxane A2 synthesis inhibition.
    Brito FC; Kummerle AE; Lugnier C; Fraga CA; Barreiro EJ; Miranda AL
    Eur J Pharmacol; 2010 Jul; 638(1-3):5-12. PubMed ID: 20412790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on platelets of patients with inherited platelet disorders suggest that collagen-induced fibrinogen binding to membrane receptors requires secreted ADP but not released alpha-granule proteins.
    Legrand C; Nurden AT
    Thromb Haemost; 1985 Oct; 54(3):603-6. PubMed ID: 3003952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased nucleotide and serotonin storage associated with defective function in Chediak-Higashi syndrome cattle and human platelets.
    Bell TG; Meyers KM; Prieur DJ; Fauci AS; Wolff SM; Padgett GA
    Blood; 1976 Aug; 48(2):175-84. PubMed ID: 949545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The phospholipase C inhibitor U73122 inhibits phorbol ester-induced platelet activation.
    Lockhart LK; McNicol A
    J Pharmacol Exp Ther; 1999 May; 289(2):721-8. PubMed ID: 10215645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of physiologic shear stresses and calcium on agonist-induced platelet aggregation, secretion, and thromboxane A2 formation.
    Viisoreanu D; Gear A
    Thromb Res; 2007; 120(6):885-92. PubMed ID: 17306868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet dysfunction in Chediak-Higashi syndrome-affected cattle.
    Shiraishi M; Ogawa H; Ikeda M; Kawashima S; Ito K
    J Vet Med Sci; 2002 Sep; 64(9):751-60. PubMed ID: 12399597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 62.